Clinical Development of Aducanumab, an Anti-Aβ Human Monoclonal Antibody Being Investigated for the Treatment of Early Alzheimer's Disease

The journal of prevention of Alzheimer's disease

Volumn 4, Issue 4, 2017, Pages 255-263

  Budd Haeberlein, S ^a   O'Gorman, J ^a   Chiao, P ^a   Bussiere T ^a   von Rosenstiel, P ^a   Tian, Y ^a   Zhu, Y ^a   von Hehn, C ^a   Gheuens, S ^a   Skordos, L ^a   Chen, T ^a   Sandrock, A ^a  

^a NONE

Author keywords

aducanumab; Alzheimer s disease; amyloid beta

Indexed keywords

ADUCANUMAB; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; CLINICAL TRIAL (TOPIC); HUMAN;

ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOLOGIC FACTORS;

EID: 85041378272     PISSN: None     EISSN: 24260266     Source Type: Journal    
DOI: 10.14283/jpad.2017.39     Document Type: Article

References (0)